AI assistant
Dolby Laboratories, Inc. — Director's Dealing 2025
Feb 7, 2025
30828_dirs_2025-02-06_2d9ab0bb-729e-4807-8de2-f8d6602c649f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2025-02-05
Reporting Person: Nicholson Ryan (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-05 | Class A Common Stock | M | 7000 | $33.15 | Acquired | 36758 | Direct |
| 2025-02-05 | Class A Common Stock | S | 7000 | $84.0686 | Disposed | 29758 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-05 | Employee Stock Option (Right to Buy) | $33.15 | M | 7000 | Disposed | 2025-12-15 | Class A Common Stock (7000) | Direct |
Footnotes
F1: Shares held following the reported transactions include 16,438 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F2: The shares were sold in multiple transactions at prices ranging from $84.02 to $84.10, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: This option was granted for a total of 7,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.